Viewpoint

This week, Science|Business launches an initiative to improve the process of innovation in Europe – an online marketplace to link scientists and industry.

Are our politicians really using science to make the best decisions? Or are they just hiding behind science, rather than using their common sense?

Asian R&D is hot. Witness our summertime sampling of news tidbits – some important, some just bizarre.

Biotech start-ups in France and elsewhere in Europe make a unique and important contribution to healthcare. They merit special treatment to help them grow.

The stock-market debut at the end of July of Imperial College London’s tech-transfer office is the best news for academic reform in years.

Complying with the EU’s labyrinthine new REACH chemicals legislation was always going to be a tortuous process. For those who wait too long, it could be impossible.

Technology transfer is a sensitive and complex process. Changing one factor won’t provide the magic bullet, says Anna S. Nilsson, Science and Technology Attaché at the Swedish Embassy in Washington DC.

It's better to have fewer, stronger, spin-offs than shoals of tiddlers, as Marina Murphy discovers.

Carlos Moreira, co-founder and chairman of Swiss data-encryption firm WISekey, talks to Science|Business editor Richard L. Hudson on the travails of entrepreneurship.

The international treaty on plant genetic resources needs a gesture of trust to repair the atmosphere of suspicion that has developed, argues Emile Frison from the International Plant Genetic Resources Institute.